Anti-DNase I Antibody A New Serological Reactivity in Primary Sjogren Syndrome

Carregando...
Imagem de Miniatura
Citações na Scopus
2
Tipo de produção
article
Data de publicação
2020
Título da Revista
ISSN da Revista
Título do Volume
Editora
LIPPINCOTT WILLIAMS & WILKINS
Citação
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, v.26, n.1, p.19-23, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background and Objective: Primary Sjogren syndrome (pSS) is a systemic autoimmune rheumatic disease that particularly affects exocrine glands. Dry eye is one of the most important features of this syndrome, and a recent study reported reduced deoxyribonuclease I (DNase I) activity in the tear of patients with dry eye. We therefore postulated that patients with pSS might have antibodies targeting DNAse I. Methods: We have evaluated in a cross-sectional study 85 patients with pSS (2002 American-European Consensus Group Criteria), 50 rheumatoid arthritis (RA) patients (1987 American College of Rheumatology Criteria) without sicca symptoms, and 88 healthy volunteers. IgG anti-DNase I was detected by enzyme-linked immunosorbent assay using as antigen bovine pancreas enzyme and confirmed by immunoblotting. Results: Age and sex were alike in the 3 groups (p > 0.05). Anti-DNase I was detected in 43.5% of the pSS patients. In contrast, this reactivity was absent in all RA patients (p = 0.0001). Additional comparison of pSS patients with (n = 37) or without (n = 48) anti-DNase I showed that the former group had higher IgG serum levels (2293.2 +/- 666.2 vs 1483.9 +/- 384.6 mg/dL, p = 0.0001) and greater rate of non-drug-induced leukopenia (43% vs 19%, p = 0.02). A multivariate logistic regression analysis identified that only IgG levels were independently associated with anti-DNase I. Conclusions: We describe a high frequency of anti-DNase I antibodies in pSS patients associated with higher serum IgG levels. The lack of this reactivity in RA patients without sicca symptoms suggests that this antibody may be helpful in the differential diagnosis of these diseases.
Palavras-chave
primary Sjogren syndrome, autoantibodies, deoxyribonuclease I, anti-DNase I, dry eye
Referências
  1. Alani H, 2018, SCAND J RHEUMATOL, V47, P141, DOI 10.1080/03009742.2017.1324909
  2. Bouma Hjalmar R, 2015, Curr Aging Sci, V8, P202
  3. Bowman SJ, 2004, SCAND J RHEUMATOL, V33, P39, DOI 10.1080/03009740310004676
  4. ESPARZA RH, 1985, J RHEUMATOL, V12, P1109
  5. Fayyaz A, 2016, RHEUM DIS CLIN N AM, V42, P419, DOI 10.1016/j.rdc.2016.03.002
  6. Fragoulis GE, 1993, NUCLEIC ACIDS RES, V21, P1999
  7. Fragoulis GE, 2015, J AUTOIMMUN, V56, P12, DOI 10.1016/j.jaut.2014.08.004
  8. Garcia-Carrasco M, 2002, MEDICINE, V81, P270, DOI 10.1097/00005792-200207000-00003
  9. Goeldner I, 2010, RHEUMATOLOGY, V49, P1590, DOI 10.1093/rheumatology/keq134
  10. Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107
  11. He J, 2011, RHEUMATOLOGY, V50, P879, DOI 10.1093/rheumatology/keq420
  12. Mahler A, 2005, CLIN DIAGN LAB IMMUN, V12, P107, DOI 10.1128/CDLI.12.1.107-113.2005
  13. Mariette X, 2018, NEW ENGL J MED, V378, P931, DOI 10.1056/NEJMcp1702514
  14. Pasoto SG, 2013, RHEUMATOL INT, V33, P1149, DOI 10.1007/s00296-012-2504-3
  15. Pasoto SG, 2012, CLIN RHEUMATOL, V31, P1331, DOI 10.1007/s10067-012-2019-z
  16. Ramos-Casals M, 2007, CLIN REV ALLERG IMMU, V32, P275, DOI 10.1007/s12016-007-8006-5
  17. Rasmussen A, 2016, RHEUMATOLOGY, V55, P1195, DOI 10.1093/rheumatology/kew023
  18. Samejima K, 2005, NAT REV MOL CELL BIO, V6, P677, DOI 10.1038/nrm1715
  19. Sanchez-Guerrero J, 2005, RHEUMATOLOGY, V44, P235, DOI 10.1093/rheumatology/keh455
  20. Seror R, 2010, ANN RHEUM DIS, V69, P1103, DOI 10.1136/ard.2009.110619
  21. Shiboski CH, 2017, ANN RHEUM DIS, V76, P9, DOI 10.1136/annrheumdis-2016-210571
  22. Sonawane S, 2012, INVEST OPHTH VIS SCI, V53, P8253, DOI 10.1167/iovs.12-10430
  23. Tibrewal S, 2013, INVEST OPHTH VIS SCI, V54, P8051, DOI 10.1167/iovs.13-12844
  24. Trofimenko AS, 2016, RHEUMATOL INT, V36, P521, DOI 10.1007/s00296-016-3437-z
  25. van der Linden MPM, 2011, ARTHRITIS RHEUM-US, V63, P37, DOI 10.1002/art.30100
  26. Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554
  27. Yeh TM, 2003, J BIOMED SCI, V10, P544, DOI 10.1159/000072382